Continuous Glucose Monitoring (CGM) Devices Market Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Continuous Glucose Monitoring (CGM) Devices Market
Diabetes is a chronic condition
brought on by either insufficient insulin production by the pancreas or
inefficient insulin utilisation by the body. For instance, the World Health
Organization reports that diabetes was the tenth largest cause of mortality
globally in 2019 and is directly responsible for an estimated 1.5 million
deaths. 9 million persons worldwide have type 1 diabetes in 2017. The bulk of
the approximately 422 million individuals with diabetes globally reside in low-
and middle-income nations, and diabetes is directly responsible for 1.5 million
fatalities annually.
Numerous factors, including rapid
urbanisation and a rising trend toward sedentary lifestyles in both developing
and industrialised nations, are contributing to an increase in the prevalence
of diabetes. By 2021, there will be 537 million adults with diabetes globally,
with Brazil, China, the United States, India, and Mexico accounting for an
estimated 51.6% of those individuals, according to the International Diabetes
Federation. The increase in type-1 or insulin-dependent Type-2 diabetic
patients has been a significant contributor to the rapid global
Continuous Glucose
Monitoring (CGM) Devices Market adoption of these monitoring
systems. Furthermore, due to favourable reimbursement rules, a sizable patient
population with insulin-dependent diabetes, and the launch of new technologies
by industry participants, there is an increasing need for diabetes monitoring
devices like CGMs.
Comments
Post a Comment